Related Experiment Video

Updated: Jul 18, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?

Paul G Auwaerter1

  • 1The Johns Hopkins University School of Medicine, Division of Infectious Diseases, 1830 East Monument Street, #449, Baltimore, MD 21205, USA. pauwaert@jhmi.edu

Expert Review of Anti-Infective Therapy
|December 22, 2006
PubMed

Insights

Symptomatic primary Epstein-Barr virus infection, or infectious mononucleosis, affects adolescents and young adults. Recent research clarifies why children are often asymptomatic while adults develop illness, and explores potential treatments and vaccines.

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • Symptomatic primary Epstein-Barr virus (EBV) infection, known as infectious mononucleosis (IM), commonly affects adolescents and young adults.
  • IM presents as a febrile illness with pharyngitis and lymphadenopathy.
  • Historically considered benign, IM is now associated with increased risks of Hodgkin's lymphoma and multiple sclerosis.

Purpose of the Study:

  • To review recent advances in understanding primary EBV infection.
  • To elucidate the immunological basis for differential disease manifestation in children versus adults.
  • To discuss potential therapeutic and vaccine strategies for EBV infection and its sequelae.

Main Methods:

  • Literature review of recent research on primary EBV infection.
  • Analysis of host immune responses to EBV.
  • Evaluation of current and prospective treatment and vaccine strategies.

Main Results:

  • Advances in understanding host immune responses explain why younger children typically experience subclinical EBV infection, while older individuals develop IM.
  • Recent studies link IM to increased risks of specific cancers and neurological disorders.
  • Emerging data suggests potential for novel therapeutic interventions and vaccine development.

Conclusions:

  • The understanding of primary EBV infection has significantly advanced, revealing complex host-pathogen interactions.
  • Differential immune responses are key to explaining varied clinical presentations of EBV.
  • Future research and interventions may mitigate the long-term risks associated with EBV infection.

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.